Published in Ned Tijdschr Geneeskd on December 12, 1987
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. Arch Intern Med (2001) 3.74
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet (1995) 2.00
Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med (1978) 1.94
Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion (1999) 1.77
KIR-ligand mismatches are associated with reduced long-term graft survival in HLA-compatible kidney transplantation. Am J Transplant (2011) 1.62
Aggregated human immunoglobulin G stabilized by albumin: a standard for immune complex detection. J Immunol Methods (1979) 1.60
Primary extranodal and nodal non-Hodgkin's lymphoma. A survey of a population-based registry. Eur J Cancer Clin Oncol (1989) 1.51
Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study. Nephrol Dial Transplant (2001) 1.50
Circulating IgA-immune complexes in Henoch-Schönlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med (1980) 1.44
A population-based registry on paraproteinaemia in The Netherlands. Comprehensive Cancer Centre West, Leiden, The Netherlands. Br J Haematol (1997) 1.43
[Radioactive phosphorus (32P); an old but not bad treatment for polycythemia vera]. Ned Tijdschr Geneeskd (1996) 1.40
Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics. Neth J Med (2003) 1.38
[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results]. Ned Tijdschr Geneeskd (2003) 1.38
Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int (1984) 1.32
Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost (1998) 1.21
Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med (1983) 1.19
Immune reconstitution after 2 years of successful potent antiretroviral therapy in previously untreated human immunodeficiency virus type 1-infected adults. J Infect Dis (1999) 1.13
Vitamin supplementation reduces blood homocysteine levels: a controlled trial in patients with venous thrombosis and healthy volunteers. Arterioscler Thromb Vasc Biol (1998) 1.09
The 5a-chromosome abnormality in haematological disorders: a collaborative study of 34 cases from the Netherlands. Br J Haematol (1982) 1.08
The clinical implications and the pathogenetic significance of circulating immune complexes in infective endocarditis. Am J Med (1981) 1.06
Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features. Clin Exp Immunol (1980) 1.05
RBC antibody persistence. Transfusion (2000) 1.04
Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy. INCAS Study Group. AIDS (1999) 1.04
The specific detection of IgA in immune complexes. J Immunol Methods (1981) 1.01
Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family. Clin Exp Immunol (1982) 0.99
A randomized trial of geriatric liaison intervention in elderly medical inpatients. Psychosom Med (1998) 0.98
Active confrontational coping predicts decreased clinical progression over a one-year period in HIV-infected homosexual men. J Psychosom Res (1995) 0.95
Long-term graft survival after urological complications of 695 kidney transplantations. J Urol (2001) 0.94
Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol (1998) 0.92
The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes. Clin Exp Immunol (1983) 0.90
High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication. J Infect Dis (1997) 0.89
Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation (2001) 0.88
Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol (1993) 0.88
Zidovudine and interferon-alpha combination therapy versus zidovudine monotherapy in subjects with symptomatic human immunodeficiency virus type 1 infection. J Infect Dis (1994) 0.87
Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity. J Infect Dis (1994) 0.87
Allergic vasculitis. A histological and immunofluorescent study of lesional and non-lesional skin in relation to circulating immune complexes. Arch Dermatol Res (1980) 0.87
Living kidney donors: impact of age on long-term safety. Am J Transplant (2011) 0.87
Fibrinopeptide A immunoreactivity in human plasma. Thromb Res (1974) 0.87
Unilateral renal vein thrombosis and nephrotic syndrome. Report of a case with protein selectivity and antithrombin III clearance studies. Am J Med (1976) 0.85
Causes of a negative ethanol gelation test in diffuse intravascular coagulation. Thromb Diath Haemorrh (1974) 0.83
Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes. Clin Nephrol (1981) 0.83
Tubulointerstitial nephritis associated with pyrazinamide. Neth J Med (1989) 0.82
Use of stenting in living donor kidney transplantation: does it reduce vesicoureteral complications? Transplant Proc (2011) 0.82
Presence of immune complex-like material in sera of patients with paraproteinaemia. J Clin Pathol (1981) 0.81
Splenomegaly associated with chronic consumption coagulopathy. Acta Med Scand (1974) 0.81
Infection with Dengue virus. Neth J Med (1992) 0.80
Fever and high lactate dehydrogenase in HIV-positive patients from the Antilles and Surinam: histoplasmosis? Neth J Med (2006) 0.80
Treatment of cytomegalovirus pneumonitis with hyperimmune plasma. Lancet (1979) 0.79
[Acute kidney insufficiency in patients treated with fumaric acid esters for psoriasis]. Ned Tijdschr Geneeskd (1989) 0.77
Acidic citrate stabilizes blood samples for assay of total homocysteine. Clin Chem (1998) 0.76
Extreme potassium loss in a patient with severe graft versus host disease. Scand J Haematol (1980) 0.75
Chronic lymphocytic leukaemia and associated second malignancy. Neth J Med (1986) 0.75
[Hyperhomocysteinemia as a risk factor for venous thrombosis]. Ned Tijdschr Geneeskd (1999) 0.75
Portosystemic encephalopathy in hereditary hemorrhagic telangiectasia. Am J Med (1988) 0.75
Bone-marrow aspiration. Br Med J (Clin Res Ed) (1981) 0.75
[Clinical reasoning and decision-making in practice. A young woman with fever, shortness of breath, and reduced consciousness]. Ned Tijdschr Geneeskd (2003) 0.75
AIDS without detectable HIV: a case report. Am J Med (1993) 0.75
Human immunodeficiency virus, fever, dyspnoea and a dry cough. Expect the unexpected? Neth J Med (1993) 0.75
Macromolecular IgA in the circulation and mesangial deposits in patients with primary IgA nephropathy. Contrib Nephrol (1984) 0.75
Kidney transplantation in patients declined by other centres. Neth J Med (2017) 0.75
Variability of the methionine loading test: no effect of a low protein diet. Ann Clin Biochem (1996) 0.75
[Splenectomy as therapy for esophageal varices in a myeloproliferative syndrome]. Ned Tijdschr Geneeskd (1990) 0.75
[Chronic hepatitis C in hemodialysis patients]. Ned Tijdschr Geneeskd (1997) 0.75
Adult T-cell leukaemia lymphoma (ATLL) associated with human T-cell leukaemia virus (HTLV). Case report and immunological studies with the neoplastic T-cells of a Caribbean patient. Neth J Med (1985) 0.75
[Intestinal necrosis in a patient with fibromuscular dysplasia and digoxin poisoning]. Ned Tijdschr Geneeskd (1988) 0.75
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status. Neth J Med (1993) 0.75
The pathogenetic significance of circulating immune complexes. Neth J Med (1984) 0.75
Hyaline-vascular type Castleman's disease with concomitant malignant B-cell lymphoma. Acta Haematol (1992) 0.75
Glycoprotein Ib polymorphism in a patient with Glanzmann's thrombasthenia type I (case report) Thromb Haemost (1990) 0.75
Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels. Transplant Proc (2002) 0.75
The elevated risk for venous thrombosis in persons with hyperhomocysteinemia is not reflected by the endogenous thrombin potential. Thromb Haemost (1999) 0.75
Dialysis associated mucormycosis and desferrioxamine treatment: a case report with review of the role of oxygen radicals. Neth J Med (1992) 0.75
The effect of anticoagulants on the size of platelets in blood smears in the course of time. Clin Lab Haematol (1991) 0.75
The spectrum of circulating immune complexes in various forms of systemic small vessel vasculitis. Neth J Med (1982) 0.75
[The recommended daily intake of folic acid is insufficient for optimum homocysteine level]. Ned Tijdschr Geneeskd (1998) 0.75
Fibrinogen and its derivatives in intravascular coagulation. A review. Neth J Med (1975) 0.75
Corticosteroids and experimental intravascular coagulation. Scand J Haematol (1974) 0.75